BLOVACITINIB
UNII DBA7WU5NH4

Substance Identification & Data

This profile provides standardized clinical and technical data for Blovacitinib, uniquely identified by the FDA Unique Ingredient Identifier (UNII) DBA7WU5NH4.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2411222-97-2 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

DBA7WU5NH4

CAS Registry Number

2411222-97-2

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

BLOVACITINIB

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C22H25F2N5O2

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

ZOUHWHPRPDJDQE-HNNXBMFYSA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C223274

National Cancer Institute reference terminology for clinical and research data.

INN ID

13644

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

c1c2n(c(cc1)C3CCC4(CC3)CN(C4)C([C@@H]5CC5(F)F)=O)nc(n2)NC(=O)C6CC6

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Blovacitinib. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.